EPG Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
EPG Wealth Management's BMY Position: Q2 2026 in Review
EPG Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 162% in Q2 2026, buying an estimated $502K and bringing the position to 14,133 shares worth $814K. The position accounts for 0.2% of the portfolio, ranked #115.
EPG Wealth Management first reported a position in BMY in Q4 2019 and has held it in 24 quarters since. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- EPG Wealth Management held 14,133 shares of Bristol-Myers Squibb worth $814K as of Q2 2026.
- EPG Wealth Management bought 8,737 Bristol-Myers Squibb shares in Q2 2026, an estimated $502K.
- Bristol-Myers Squibb made up 0.2% of EPG Wealth Management's portfolio in Q2 2026, its #115 holding.
- EPG Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 24 quarters since.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on EPG Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.